Press Releases April 27, 2026 08:30 AM

Gaia Sets First Quarter 2026 Conference Call for Monday, May 4, 2026, at 4:30 p.m. ET

Gaia, Inc. to host Q1 2026 earnings conference call on May 4, 2026

By Marcus Reed
Share
Twitter Reddit Facebook LinkedIn
GAIA

Gaia, Inc., a conscious streaming platform specializing in health, wellness, and spiritual growth content, announced that it will report its first quarter 2026 financial results and host an earnings conference call on May 4, 2026. The company offers over 10,000 exclusive titles and services members in 185 countries across multiple streaming platforms.

Gaia Sets First Quarter 2026 Conference Call for Monday, May 4, 2026, at 4:30 p.m. ET
GAIA
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Gaia operates a niche streaming platform with over 10,000 titles focused on health, wellness, and spiritual content, available globally in four languages.
  • The company services its community through various platforms including Apple TV, iOS, Android, Amazon Fire, Roku, and partnerships with Amazon Prime Video and Comcast Xfinity.
  • The upcoming earnings call will provide insights into Gaia's Q1 2026 financial performance amidst an evolving streaming market landscape.

BOULDER, Colo., April 27, 2026 (GLOBE NEWSWIRE) -- Gaia, Inc. (NASDAQ: GAIA), the world's largest conscious streaming platform with 10,000 videos dedicated to health, wellness and spiritual growth, will conduct a conference call on Monday, May 4, 2026, at 4:30 p.m. Eastern time (2:30 p.m. Mountain time) to discuss its financial results for the first quarter ended March 31, 2026. The company will report its financial results in a press release prior to the call.

Gaia management will host the conference call, followed by a question and answer period.

Date: Monday, May 4, 2026
Time: 4:30 p.m. Eastern time (2:30 p.m. Mountain time)
Toll-free dial-in number: 1-877-269-7751
International dial-in number: 1-201-389-0908
Conference ID: 13759800

Please call the conference telephone number 5-10 minutes prior to the start time. An operator will register your name and organization. If you have any difficulty connecting with the conference call, please contact Gateway Group at 949-574-3860.

The conference call will be broadcast live and available for replay here and via ir.gaia.com.

A telephonic replay of the conference call will be available after 7:30 p.m. Eastern time on the same day through May 18, 2026.

Toll-free replay number: 1-844-512-2921
International replay number: 1-412-317-6671
Replay ID: 13759800

About Gaia

Gaia is a member-supported global video streaming service and community that produces and curates conscious media through four primary channels — Seeking Truth, Transformation, Alternative Healing and Yoga — in four languages (English, Spanish, French and German) to its members in 185 countries. Gaia's library includes over 10,000 titles, over 85% of which is exclusive to Gaia, and approximately 75% of viewership is generated by content produced or owned by Gaia. Gaia is available on Apple TV, iOS, Android, Amazon Fire, Roku, Chromecast, and sold through Amazon Prime Video and Comcast Xfinity. For more information, visit www.gaia.com.

Company Contact:

Ned Preston
Chief Financial Officer
Gaia, Inc.
Investors@gaia.com

Investor Relations:

Cody Slach
Gateway Group, Inc.
949-574-3860
GAIA@gateway-grp.com


Risks

  • Market competition in the streaming sector may affect Gaia's subscriber growth and revenue.
  • Dependence on member subscriptions implies vulnerability to shifts in consumer spending and engagement within the wellness and spiritual niches.
  • Global economic or regulatory changes across the 185 countries served could impact content distribution and platform accessibility.

More from Press Releases

Phase 3 Data Show TransCon® PTH Replicated Systemic Actions of Endogenous PTH Through Week 182 in Adults with Hypoparathyroidism Jun 13, 2026 Agios Showcases RISE UP Phase 3 Results at EHA 2026 Plenary Session Reinforcing Strong Anti-Hemolytic Profile of Mitapivat in Sickle Cell Disease Jun 13, 2026 Rhythm Pharmaceuticals Presents Positive Interim Six-month Data from Phase 2 Trial of Setmelanotide in Patients with Prader-Willi Syndrome (PWS) at ENDO 2026 Jun 13, 2026 Intellia Therapeutics Reports Additional Positive Phase 3 Results for Lonvoguran Ziclumeran (lonvo-z) in Patients with Hereditary Angioedema Jun 13, 2026 Arcadia Biosciences (RKDA) Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules Jun 12, 2026